489 related articles for article (PubMed ID: 25776887)
1. Curcumin Binding to Beta Amyloid: A Computational Study.
Rao PP; Mohamed T; Teckwani K; Tin G
Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
[TBL] [Abstract][Full Text] [Related]
2. The effect of curcumin on the stability of Aβ dimers.
Zhao LN; Chiu SW; Benoit J; Chew LY; Mu Y
J Phys Chem B; 2012 Jun; 116(25):7428-35. PubMed ID: 22690789
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of clicked curcumin and clicked KLVFFA conjugates as inhibitors of beta-amyloid fibril formation.
Ouberai M; Dumy P; Chierici S; Garcia J
Bioconjug Chem; 2009 Nov; 20(11):2123-32. PubMed ID: 19821579
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies.
Azam F; Alabdullah NH; Ehmedat HM; Abulifa AR; Taban I; Upadhyayula S
J Biomol Struct Dyn; 2018 Jun; 36(8):2099-2117. PubMed ID: 28571516
[TBL] [Abstract][Full Text] [Related]
6. Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease.
Orjuela A; Lakey-Beitia J; Mojica-Flores R; Hegde ML; Lans I; Alí-Torres J; Rao KS
J Alzheimers Dis; 2021; 82(s1):S321-S333. PubMed ID: 33337368
[TBL] [Abstract][Full Text] [Related]
7. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
8. Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils.
Martin TD; Malagodi AJ; Chi EY; Evans DG
J Phys Chem B; 2019 Jan; 123(3):551-560. PubMed ID: 30571122
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease.
Kundaikar HS; Degani MS
Chem Biol Drug Des; 2015 Oct; 86(4):805-12. PubMed ID: 25763767
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the photoluminescence response of light-switching ruthenium(II) complexes bound to amyloid-β.
Cook NP; Ozbil M; Katsampes C; Prabhakar R; Martí AA
J Am Chem Soc; 2013 Jul; 135(29):10810-6. PubMed ID: 23845146
[TBL] [Abstract][Full Text] [Related]
11. Curcumin derivatives as new ligands of Aβ peptides.
Airoldi C; Zona C; Sironi E; Colombo L; Messa M; Aurilia D; Gregori M; Masserini M; Salmona M; Nicotra F; La Ferla B
J Biotechnol; 2011 Dec; 156(4):317-24. PubMed ID: 21807037
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
Sun Y; Qian Z; Wei G
Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
[TBL] [Abstract][Full Text] [Related]
14. Anti-arrhythmic Medication Propafenone a Potential Drug for Alzheimer's Disease Inhibiting Aggregation of Aβ: In Silico and in Vitro Studies.
Ngo ST; Fang ST; Huang SH; Chou CL; Huy PD; Li MS; Chen YC
J Chem Inf Model; 2016 Jul; 56(7):1344-56. PubMed ID: 27304669
[TBL] [Abstract][Full Text] [Related]
15. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
16. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
17. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
[TBL] [Abstract][Full Text] [Related]
18. Structures of Aβ17-42 trimers in isolation and with five small-molecule drugs using a hierarchical computational procedure.
Chebaro Y; Jiang P; Zang T; Mu Y; Nguyen PH; Mousseau N; Derreumaux P
J Phys Chem B; 2012 Jul; 116(29):8412-22. PubMed ID: 22283547
[TBL] [Abstract][Full Text] [Related]
19. A "keto-enol" plaque buster mechanism to diminish Alzheimer's β-Amyloid burden.
Zoltán O; László P; Éva K; Béla V
Biochem Biophys Res Commun; 2020 Oct; 532(1):82-87. PubMed ID: 32828536
[TBL] [Abstract][Full Text] [Related]
20. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
